JX Advanced Metals Corporation
5016
Medix Inc.
331A
TalentX Inc.
330A
Tential
325A
Booking Resort
324A
JP Stock MarketDetailed Quotes
4883 Modalis Therapeutics
- 86
- 00.00%
20min DelayMarket to Open Mar 11 15:30 JST
6.25BMarket Cap-1.11P/E (Static)
0High0Low0Volume0Open86Pre Close0.00Turnover20352wk High0.00%Turnover Ratio72.69MShares6252wk Low-64.98EPS TTM5.63BFloat Cap4070Historical HighLossP/E (Static)65.45MShs Float62Historical Low-77.24EPS LYR0.00%Amplitude--Dividend TTM5.36P/B100Lot Size--Div YieldTTM
About Modalis Therapeutics Company
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.
Company Profile
Symbol4883
Company NameModalis Therapeutics
Founded2016-01-14
MarketTSE Growth
Employees37
Fiscal Year Ends12-31
Address16-5 Nihombashi-Kabuto-cho Chuo-ku
Zip Code103-0023
Phone03-6822-4584
Websitemodalistx.com
Company Executives
- Name
- Position
- Salary
- Haruhiko Morita
- Representative Director and President
- --
- Teruhisa Tashima
- Independent Director
- --
- Miyuki Shimane
- Independent Director
- --
- Joseph McCracken
- Independent Director
- --
- Hideki Takeda
- Independent Director
- --
- Toshio Furuta
- Independent Director
- --